Ciprofloxacin

Type: Product

Name: Ciprofloxacin

First reported Jun 17 2013 - Updated 7 hours ago - 1 reports

Shares of RDY Up 11.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on March 12th, 2013 at $33.65. In approximately 3 months, Dr Reddys Laboratories has returned 11.52% as of today's recent price of $37.52.In the past 52 weeks, Dr Reddys Laboratories ... [Published Comtex SmarTrend - Jun 17 2013]

Entities: Dr Reddy's Laboratories Ltd, Stocks, Verapamil, Cephalexin, Penicillin

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

The Culturable Soil Antibiotic Resistome: A Community of Multi-Drug Resistant Bacteria

by Fiona Walsh, Brion DuffyUnderstanding the soil bacterial resistome is essential to understanding the evolution and development of antibiotic resistance, and its spread between species and biomes. We have identified and characterized multi-drug resistance ... [Published Elites TV - Jun 13 2013]

Entities: Antibiotic, Bacteria, Soil, Burkholderia

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Commonly Prescribed Antibiotics May Injure Kidneys

http://www.doctorshealthpress.com/general-health-2/commonly-prescribed-antibiotics-may-injure-kidneys Antibiotics have a proud history in helping us fight infections. However, of late, medical experts are expressing concern over the misuse of antibiotics. ... [Published Now Public - Jun 13 2013]

Entities: Antibiotics, Antibiotic, Fluoroquinolones, Avelox, Drugs

First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Bayer AG

Summit appoints Pfizer/Bayer veteran as CMO

David Roblin to lead development of therapies for Duchenne muscular dystrophy and C.difficileIndustry veteran Dr David Roblin has joined the Oxford, UK-based drug development and discovery company Summit as its chief medical officer.Dr Roblin has years ... [Published PMLive - Jun 13 2013]

Entities: David Roblin, Bayer AG, Pfizer Inc

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Drug targeting of phages could offer a potential new path to mitigate antibiotic resistance

Bacteria in the gut that are under attack by antibiotics have allies no one had anticipated, a team of Wyss Institute scientists has found. Gut viruses that usually commandeer the bacteria, it turns out, enable them to survive the antibiotic onslaught, ... [Published News-Medical.Net - Jun 11 2013]

Entities: Bacteriophage, Antibiotic, Bacteria

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Ciprofloxacin

CIPROFLOXACIN HYDROCHLORIDEtablet [KAISER FOUNDATION HOSPITALS]

Updated Date: Jun 4, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jun 04 2013]

Entities: Kaiser Fndtn Hosps, Ciprofloxacin

First reported Jun 03 2013 - Updated Jun 04 2013 - 4 reports

Risk of acute kidney disease doubles if you take these antibiotics

If you take a certain class of antibiotics, you may be doubling your risk of acute kidney disease, according to a study published June 3, 2013 in the Canadian Medical Association Journal (CMAJ).Fluoroquinolone antibiotics, which include ciprofloxacin ... [Published EMax Health - Jun 04 2013]

Entities: Antibiotic, Kidney, Risk (Health)

First reported May 30 2013 - Updated May 31 2013 - 4 reports

Several prescription drugs recalls issued

Four companies have announced the recall of several batches of prescription drugs in Canada.Health Canada said it has not received any reports of adverse effects.This is a precautionary measure.The companies involved are Cobalt Pharmaceuticals, Laboratoire ... [Published News 95.7 Halifax - May 31 2013]

Entities: Drugs, Hypertension, Telmisartan, infections, lamotrigine

First reported May 28 2013 - Updated May 28 2013 - 1 reports

"Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris"

Fluoroquinolones are used with increasing frequency in children with a major risk of increasing the emergence of FQ resistance. FQ use has expanded off-label for primary antibacterial prophylaxis or treatment of infections in immune-compromised children ... [Published BMC - May 28 2013]

Entities: Ciprofloxacin, Infection, Pseudomonas Aeruginosa, Paris

First reported May 23 2013 - Updated May 23 2013 - 3 reports

Grifols, Aradigm sign licensing agreement to develop, commercialize Pulmaquin

Grifols, a global healthcare company, and Aradigm, an emerging specialty pharmaceutical company focused severe respiratory diseases, have signed an exclusive worldwide license for Aradigm's proprietary formulations of inhaled ciprofloxacin (Pulmaquin ... [Published Center Watch - May 23 2013]

Entities: Aradigm Corporation, Grifols SA, Pulmaquin

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Patent Application Titled "Ciprofloxacin Dry Syrup Compositi. . .

Patent Application Titled "Ciprofloxacin Dry Syrup Composition" Published OnlinePatentsNewsRx.comBy a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, ... [Published Equities.com - May 22 2013]

Entities: Ciprofloxacin, Invention, Polymer, Active Ingredient, Solvent

First reported May 21 2013 - Updated May 21 2013 - 3 reports

Grifols Taking Aradigm Stake in Up To $116M Licensing Deal

Grifols will take a $26-million, roughly one-third stake in Aradigm under an exclusive, worldwide up-to-$116 million-plus license to develop and commercialize the latter’s inhaled ciprofloxacin formulations (Pulmaquin™ and Lipoquin™) for severe respiratory ... [Published Genetic Engineering News - May 21 2013]

Entities: Aradigm Corporation, Grifols SA, Pulmaquin, Ciprofloxacin

Quotes

"Secondly, we will invite tenders from small and medium enterprises (SMEs) manufacturing generic drugs" the official said

Soon youll get cheaper medicines at govt stores [Published Hindustan Times - 4 hours ago]

...The project "s outcomes will help clinicians to rapidly select the most appropriate antibiotic for therapeutic purposes as well as help them estimate the likelihood of resistance following treatment with major antibiotics."

2013-06-13 - Battling antibiotic-resistant bacteria [Published Cordis - Jun 14 2013]

"David brings considerable expertise in all aspects of drug development having been instrumental in the successful development of a number of important medicines,” said Summit's CEO Glyn Edwards."

Summit appoints Pfizer/Bayer veteran as CMO [Published PMLive - Jun 13 2013]

"When we treat mice with certain classes of drugs, we see enrichment of resistance genes to those drug classes" Modi said

Drug targeting of phages could offer a potential new path to mitigate antibiotic resistance [Published News-Medical.Net - Jun 11 2013]

More Content

sort by: Date \| Relevance
Litigation Alert: Supreme Court Rules on “Rever... [Published JD Supra - 4 hours ago]
Soon youll get cheaper medicines at govt stores [Published Hindustan Times - 4 hours ago]
Honduran Politicians' Aversion to Writing [Published Hondurasweekly - 7 hours ago]
Shares of RDY Up 11.5% Since Uptrend Call on Sh... [Published Comtex SmarTrend - Jun 17 2013]
AMD’s SeaMicro SM15000 Server Achieves Certific... [Published AMD Zone - Jun 14 2013]
2013-06-13 - Battling antib... [Published Cordis - Jun 14 2013]
The Culturable Soil Antibiotic Resistome: A Com... [Published Elites TV - Jun 13 2013]
Commonly Prescribed Antibiotics May Injure Kidneys [Published Now Public - Jun 13 2013]
Daniel Grotkiewicz [Published Ozaukee Press - Jun 13 2013]
Wilbert Klapperich [Published Ozaukee Press - Jun 13 2013]
Summit appoints Pfizer/Bayer veteran as CMO [Published PMLive - Jun 13 2013]
Microbial Keratitis and Contact Lens Wear [Published Contact Lens Spectrum - Jun 12 2013]
CIPROFLOXACIN Tablet, Film Coated [Mylan Pharma... [Published DailyMed Drug Label Updates for the last seven ... - Jun 11 2013]
Drug targeting of phages could offer a potentia... [Published News-Medical.Net - Jun 11 2013]
What your doctor won't tell you about painkille... [Published Mail Online UK - Jun 11 2013]
What can I do to get rid of corns? [Published Scottish Daily Express - Jun 11 2013]
Jorge Montenegro's "Humorous Stories" [Published Hondurasweekly - Jun 10 2013]
Viruses in gut confer antibiotic resistance to ... [Published Medical Xpress - Jun 10 2013]
A potential new target to thwart antibiotic res... [Published EurekAlert! - Jun 10 2013]
Dr Reddys Laboratories Has Returned 12.1% Since... [Published Comtex SmarTrend - Jun 10 2013]
Trust in the Pill Bottle [Published BioPharm International - Jun 10 2013]
Buying medicines on your travels [Published Wanderlust Travel Magazine - Jun 10 2013]
nfxB as a Novel Target for Analysis of Mutation... [Published Elites TV - Jun 10 2013]
Use of Fluoroquinolone Antibiotics Linked to Hi... [Published MedIndia - Jun 08 2013]
Global Respiratory Tract Infections Report - Pi... [Published Individual.com - Jun 06 2013]
Antibiotics Doubles Risk of Kidney Disease [Published Medical Breakthroughs - Jun 06 2013]
Gertrude “Trudi” M. Bloecher [Published Ozaukee Press - Jun 05 2013]
Hattie J. Peiffer [Published Ozaukee Press - Jun 05 2013]
Patricia Kotecki [Published Ozaukee Press - Jun 05 2013]
Ranbaxy case: Should Indian patients worry over... [Published IBNLive India News - Jun 05 2013]

sort by: Date \| Relevance
SALVAT Completes Enrollment of Phase III Study ... [Published Business Wire Health News - May 28 2013]
SALVAT Completes Enrollment of Phase III Study ... [Published EON Science - May 28 2013]
SALVAT Completes Enrollment of Phase III Study ... [Published Business Wire Science: Science News - May 28 2013]
Grifols, S.A. and Aradigm Corporation Announce ... [Published Business Wire Photo/Multimedia News - May 21 2013]
Grifols, S.A. and Aradigm Corporation Announce ... [Published Business Wire Manufacturing News - May 21 2013]